ESSA Pharma Inc. 4 SEC Filings

Filed On	Filing
15 Oct 2025	Form 4: Parkinson David Ross, Director Returned 65,675 shares to the issuer
15 Oct 2025	Form 4: Wood David S., Chief Financial Officer Returned 33,343 shares to the issuer
15 Oct 2025	Form 4: Berger Franklin M, Director Returned 784,404 shares to the issuer
15 Oct 2025	Form 4: Glickman Richard M, Director Returned 43,240 shares to the issuer
15 Oct 2025	Form 4: Requadt Scott, Director Returned 30,002 shares to the issuer
15 Oct 2025	Form 4: Martin John Alexander, Director Returned 14,299 shares to the issuer
15 Oct 2025	Form 4: Thorell Marella, Director Returned 2,881 shares to the issuer
14 Oct 2025	Form 4: Bvf Partners L P/IL, 10% owner and 9 others Disposed of 11,481,685 shares (Tender Offer)
07 Aug 2025	Form 4: Bvf Partners L P/IL, 10% owner and 9 others Received 2,920,000 shares by exercise ($292) · Sold 156 shares ($293)
05 Nov 2024	Form 4: Biotech Growth N V, 10% owner and 1 other Sold 7,879,583 shares ($12M)
07 Oct 2024	Form 4: Virsik Peter, Chief Operating Officer Sold 694 shares ($4.18K)
09 Sep 2024	Form 4: Virsik Peter, Chief Operating Officer Sold 694 shares ($4.16K)
03 Sep 2024	Form 4: Virsik Peter, Chief Operating Officer Sold 2,082 shares ($12.6K)
06 May 2024	Form 4: Virsik Peter, Chief Operating Officer Sold 694 shares ($4.82K)
25 Apr 2024	Form 4: Glickman Richard M, Director Received 3,750 shares by exercise or conversion ($18.4K)
05 Apr 2024	Form 4: Virsik Peter, Chief Operating Officer Sold 694 shares ($5.51K)
28 Mar 2024	Form 4: Zweifach Sanford S, Director Granted 50,000 Options
28 Mar 2024	Form 4: Thorell Marella, Director Granted 50,000 Options
28 Mar 2024	Form 4: Sollis Gary, Director Granted 50,000 Options
28 Mar 2024	Form 4: Requadt Scott, Director Granted 50,000 Options

Comments